SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 58.15+5.4%Jan 6 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scott_jiminez who wrote (8708)6/20/2003 5:32:35 PM
From: Madharry   of 52153
 
perhaps that is your perspective. it certainly is not mine.

the dot.coms were ridiclulously overpriced to begin with.
the telecoms were not as clear to me and i speculated in a few that did go broke. in hindsight fraudulent large companies were perpetrating a myth with the help of investment bankers/analysts and dragging investors, suppliers, and smaller wannabes down with them. the clecs, and many cell companies were flat out business failures. there have been few biotechs to have gone belly-up and many of them have cash and have figured out ways to conserve cash. there have been success stories and there will be some future ones. and the fda haveing a more benevolent postion towards approvals is going to help.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News